KNOMATIC
Live / Allowed — Notice of allowance issued (as of 01 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Aug 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98720113
- Mark type
- Word mark
- Filed
- 27 Aug 2024
- Published for opposition
- 07 Jul 2026
- Attorney of record
- Gregory B. Coy
Goods and services
- Class 005 — Pharmaceuticals: chemical and biochemical preparations and substances for medical purposes for treatment and diagnosis of cancer, autoimmune disease, and other diseases that involve the functionality of highly dynamic proteins; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders
Owner
- Moma Therapeutics, Inc., Cambridge, MA, US
- Moma Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 01 Sept 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jul 2026 — PUBLISHED FOR OPPOSITION
- 01 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Jun 2026 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 27 May 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 May 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 27 May 2026 — EXAMINER'S AMENDMENT ENTERED
- 27 May 2026 — EXAMINERS AMENDMENT E-MAILED
- 27 May 2026 — EXAMINERS AMENDMENT -WRITTEN
- 10 Feb 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 10 Feb 2026 — FINAL REFUSAL E-MAILED
- 10 Feb 2026 — FINAL REFUSAL WRITTEN
- 12 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE